Angiogenesis is one of the hallmarks of cancer, including brain tumors. Malignant gliomas have the highest degree of vascular proliferation among solid tumors; thus, angiogenic pathways represent an attractive target to interfere with tumor growth. Up to date VEGF pathway targeting with specific drugs has yielded interesting therapeutics results. In particular bevacizumab, a monoclonal antibody against VEGF-A, has shown clinical activity in malignant gliomas, especially glioblastomas, in terms of a high response rate on MRI and a significant increase in progression-free survival.
Titolo: | Antiangiogenic therapy of brain tumors: The role of bevacizumab | |
Autori Riconosciuti: | ||
Autori: | Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo | |
Data di pubblicazione: | 2014 | |
Abstract: | Angiogenesis is one of the hallmarks of cancer, including brain tumors. Malignant gliomas have the highest degree of vascular proliferation among solid tumors; thus, angiogenic pathways represent an attractive target to interfere with tumor growth. Up to date VEGF pathway targeting with specific drugs has yielded interesting therapeutics results. In particular bevacizumab, a monoclonal antibody against VEGF-A, has shown clinical activity in malignant gliomas, especially glioblastomas, in terms of a high response rate on MRI and a significant increase in progression-free survival. | |
Volume: | 35 | |
Fascicolo: | 4 | |
Pagina iniziale: | 507 | |
Pagina finale: | 514 | |
Digital Object Identifier (DOI): | 10.1007/s10072-014-1627-6 | |
URL: | link.springer.de/link/service/journals/10072/index.htm | |
Parole Chiave: | Angiogenesis; Bevacizumab; Glioblastoma; High-grade glioma; VEGF; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain; Brain Neoplasms; Glioblastoma; Humans; Vascular Endothelial Growth Factors; Neurology (clinical); Psychiatry and Mental Health; 2708 | |
Rivista: | NEUROLOGICAL SCIENCES | |
Appare nelle tipologie: | 03B-Review in Rivista / Rassegna della Lett. in Riv. / Nota Critica |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.